Edition:
United Kingdom

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

1.78USD
15 Jan 2019
Change (% chg)

-- (--)
Prev Close
$1.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
33,629
52-wk High
$13.90
52-wk Low
$1.22

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -1.651
Jun '18 0.00 -1.687
Mar '18 0.00 -2.068
FY 2017 Dec '17 0.00 -3.220
Sep '17 0.00 -2.576
Jun '17 0.00 -2.319
Mar '17 0.00 -2.407
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 2 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-19 1 -1.01 -1.01 -1.01 --
Quarter Ending Jun-19 1 -0.88 -0.88 -0.88 --
Year Ending Dec-19 2 -2.49 -1.20 -3.78 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.12 34.38
P/E High - Last 5 Yrs. -- 40.55 46.19
P/E Low - Last 5 Yrs. -- 23.99 24.58
Beta 1.02 0.91 0.91
Price to Sales (TTM) -- 4.00 6.26
Price to Book (MRQ) 2.13 5.02 5.20
Price to Tangible Book (MRQ) 2.60 5.76 6.73
Price to Cash Flow (TTM) -- 23.21 24.17
% Owned Institutions 7.03 0.94 1.75

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.44
Dividend Yield - 5 Year Avg -- 1.56 1.46
Dividend 5 Year Growth Rate -- 4.22 4.93
Payout Ratio(TTM) -- 45.69 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.31 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 4.77 6.48
Sales - 5 Yr. Growth Rate -- 10.00 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago 52.94 17.44 23.23
EPS (TTM) vs TTM 1 Yr. Ago -33.17 -- --
EPS - 5 Yr. Growth Rate -- 9.90 10.50
Capital Spending - 5 Yr. Growth Rate -9.41 15.23 14.62

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.30
Current Ratio (MRQ) 5.88 3.02 3.12
LT Debt to Equity (MRQ) 0.03 8.85 11.47
Total Debt to Equity (MRQ) 0.06 12.66 16.03
Interest Coverage (TTM) -- 35.18 30.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.40 54.45
Gross Margin - 5 Yr. Avg. -- 51.85 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.40 13.10
Operating Margin (TTM) -- 14.43 6.05
Operating Margin - 5 Yr. Avg. -- 14.54 8.39
Pre-Tax Margin (TTM) -- 14.96 7.01
Pre-Tax Margin - 5 Yr. Avg. -- 14.97 8.67
Net Profit Margin (TTM) -- 11.16 3.11
Net Profit Margin - 5 Yr. Avg. -- 11.22 4.86
Effective Tax Rate (TTM) -- 23.47 23.27
Effective Tax Rate - 5 Yr. Avg. -- 23.66 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 997,645,050 873,304,761
Net Income/Employee (TTM) -725,656 118,307,527 103,509,273
Receivable Turnover (TTM) -- 5.82 5.80
Inventory Turnover (TTM) -- 2.68 3.57
Asset Turnover (TTM) 0.00 0.99 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -90.79 11.99 11.45
Return on Assets - 5 Yr. Avg. -75.22 13.28 12.50
Return on Investment (TTM) -103.68 15.55 14.96
Return on Investment - 5 Yr. Avg. -115.63 17.29 16.23
Return on Equity (TTM) -105.20 16.93 16.53
Return on Equity - 5 Yr. Avg. -127.41 18.21 17.36
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 80.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellectar Biosciences Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 10.65 6.83 81 20
13 Week 9.94 4.58 77 34
26 Week -20.97 -26.98 21 28
52 Week -34.29 -44.31 14 12
YTD 40.57 23.45 82 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.70%
# of Holders: 20
Total Shares Held: 556,439
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.